Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Is a |
Product containing ceftazidime (medicinal product) |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ceftazidime (substance) |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Has manufactured dose form |
injection |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Has manufactured dose form |
Powder for solution for injection |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Is a |
Ceftazidime-containing product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Has presentation strength numerator value |
250 |
false |
Inferred relationship |
Some |
1 |
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
This attribute specifies the denominator unit for the presentation strength of a product. |
Vial (unit of presentation) |
false |
Inferred relationship |
Some |
1 |
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Has unit of presentation |
Vial (unit of presentation) |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
false |
Inferred relationship |
Some |
1 |
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Ceftazidime pentahydrate (substance) |
false |
Inferred relationship |
Some |
1 |
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Ceftazidime (substance) |
false |
Inferred relationship |
Some |
1 |
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Is a |
Ceftazidime only product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|
ceftazidime 250 mg, flacon de poudre pour solution injectable |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|